Related references
Note: Only part of the references are listed.Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic efficacy
Satoru Watanabe et al.
ANTIVIRAL RESEARCH (2016)
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
Nicholas J. Barrows et al.
CELL HOST & MICROBE (2016)
Viral evasion of intracellular DNA and RNA sensing
Ying Kai Chan et al.
NATURE REVIEWS MICROBIOLOGY (2016)
The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model
Beth D. Kirkpatrick et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Status of vaccine research and development of vaccines for dengue
Kirsten S. Vannice et al.
VACCINE (2016)
Protective and immunological behavior of chimeric yellow fever dengue vaccine
Scott B. Halstead et al.
VACCINE (2016)
Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity
Kuan Rong Chan et al.
NATURE MICROBIOLOGY (2016)
Yellow Fever in a Worker. Returning to China from Angola, March 2016
Yun Ling et al.
EMERGING INFECTIOUS DISEASES (2016)
The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development
Dahai Luo et al.
ANTIVIRAL RESEARCH (2015)
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
S. R. Hadinegoro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
Luis Villar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Modeling the impact on virus transmission of Wolbachia-mediated blocking of dengue virus infection of Aedes aegypti
Neil M. Ferguson et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination
P. Robert Beatty et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity
Naphak Modhiran et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward
Bruno Guy et al.
VACCINE (2015)
New insights into the immunopathology and control of dengue virus infection
Gavin Screaton et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope
Luke N. Robinson et al.
CELL (2015)
Dengue Human Infection Models Supporting Drug Development
James Whitehorn et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Activation of Peripheral Blood Mononuclear Cells by Dengue Virus Infection Depotentiates Balapiravir
Yen-Liang Chen et al.
JOURNAL OF VIROLOGY (2014)
Characterization of the Mode of Action of a Potent Dengue Virus Capsid Inhibitor
Pietro Scaturro et al.
JOURNAL OF VIROLOGY (2014)
Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
Jenny G. Low et al.
LANCET INFECTIOUS DISEASES (2014)
Lovastatin Delays Infection and Increases Survival Rates in AG129 Mice Infected with Dengue Virus Serotype 2
Marlen Martinez-Gutierrez et al.
PLOS ONE (2014)
Dengue Therapeutics, Chemoprophylaxis, and Allied Tools: State of the Art and Future Directions
James Whitehorn et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
First Experimental In Vivo Model of Enhanced Dengue Disease
Junqi Song
PLOS PATHOGENS (2014)
First Experimental In Vivo Model of Enhanced Dengue Disease Severity through Maternally Acquired Heterotypic Dengue Antibodies
Jowin Kai Wei Ng et al.
PLOS PATHOGENS (2014)
Short Report: Comparison of the Mosquito Inoculation Technique and Quantitative Real Time Polymerase Chain Reaction to Measure Dengue Virus Concentration
Milly M. Choy et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein
Chelsea M. Byrd et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Experimental therapies for yellow fever
Justin G. Julander
ANTIVIRAL RESEARCH (2013)
Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication
Koen W. R. van Cleef et al.
ANTIVIRAL RESEARCH (2013)
The flavivirus NS1 protein: Molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker
David A. Muller et al.
ANTIVIRAL RESEARCH (2013)
Therapeutic antibodies as a treatment option for dengue fever
Kuan Rong Chan et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients
Nguyet Minh Nguyen et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Inhibition of Megakaryocyte Development in the Bone Marrow Underlies Dengue Virus-Induced Thrombocytopenia in Humanized Mice
Aishwarya Sridharan et al.
JOURNAL OF VIROLOGY (2013)
Immature and Mature Dengue Serotype 1 Virus Structures Provide Insight into the Maturation Process
Victor A. Kostyuchenko et al.
JOURNAL OF VIROLOGY (2013)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial
Satoru Watanabe et al.
ANTIVIRAL RESEARCH (2012)
Structural biology of dengue virus enzymes: Towards rational design of therapeutics
Christian G. Noble et al.
ANTIVIRAL RESEARCH (2012)
Effects of Short-Course Oral Corticosteroid Therapy in Early Dengue Infection in Vietnamese Patients: A Randomized, Placebo-Controlled Trial
Dong T. H. Tam et al.
CLINICAL INFECTIOUS DISEASES (2012)
Highly Potent Inhibitors of Proprotein Convertase Furin as Potential Drugs for Treatment of Infectious Diseases
Gero L. Becker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Magnitude of Dengue Virus NS1 Protein Secretion Is Strain Dependent and Does Not Correlate with Severe Pathologies in the Mouse Infection Model
Satoru Watanabe et al.
JOURNAL OF VIROLOGY (2012)
USE OF PENTOXIFYLLINE IN TREATMENT OF CHILDREN WITH DENGUE HEMORRHAGIC FEVER
Doris Salgado et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model
Abhay P. S. Rathore et al.
ANTIVIRAL RESEARCH (2011)
Combination of alpha-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2011)
Kinetics of Plasma Viremia and Soluble Nonstructural Protein 1 Concentrations in Dengue: Differential Effects According to Serotype and Immune Status
Huynh T. L. Duyen et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
Martina Beltramello et al.
CELL HOST & MICROBE (2010)
Use of Cytomegalovirus Intravenous Immune Globulin for the Adjunctive Treatment of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Bryan T. Alexander et al.
PHARMACOTHERAPY (2010)
Report of an NIAID workshop on dengue animal models
M. Cristina Cassetti et al.
VACCINE (2010)
A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults
Vianney Tricou et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
A Small-Molecule Dengue Virus Entry Inhibitor
Qing-Yin Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Efficacy of low dose dexamethasone in severe thrombocytopenia caused by dengue fever: a placebo controlled study
S. A. M. Kularatne et al.
POSTGRADUATE MEDICAL JOURNAL (2009)
Towards the design of antiviral inhibitors against flaviviruses: The case for the multifunctional NS3 protein from Dengue virus as a target
Julien Lescar et al.
ANTIVIRAL RESEARCH (2008)
The flavivirus precursor membrane-envelope protein complex: Structure and maturation
Long Li et al.
SCIENCE (2008)
Structure of the immature dengue virus at low pH primes proteolytic maturation
I-Mei Yu et al.
SCIENCE (2008)
A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs
Wouter Schul et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
The use of homeopathic combination remedy for dengue fever symptoms: a pilot RCT in Honduras
J. Jacobs et al.
HOMEOPATHY (2007)
Structure of the dengue virus envelope protein after membrane fusion
Y Modis et al.
NATURE (2004)
High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever
DH Libraty et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion
RJ Kuhn et al.
CELL (2002)
Passive immunity in prevention and treatment of infectious diseases
MA Keller et al.
CLINICAL MICROBIOLOGY REVIEWS (2000)
Share Paper
